Plus therapeutics to present at the 2023 virtual june investor summit

Austin, texas, may 25, 2023 (globe newswire) -- plus therapeutics, inc. (nasdaq:  pstv ) (the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, announced today that marc hedrick, m.d., president and chief executive officer, will present at the 2023 virtual june investor summit on thursday, june 1, 2023, at 2:00 p.m. et.
pstv Ratings Summary
pstv Quant Ranking